174 related articles for article (PubMed ID: 34003290)
1. Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women With Bacterial Vaginosis Are Associated With Metronidazole Treatment Response.
Serebrenik J; Wang T; Hunte R; Srinivasan S; McWalters J; Tharp GK; Bosinger SE; Fiedler TL; Atrio JM; Murphy K; Barnett R; Ray LR; Krows ML; Fredricks DN; Irungu E; Ngure K; Mugo N; Marrazzo J; Keller MJ; Herold BC
J Infect Dis; 2021 Dec; 224(12):2094-2104. PubMed ID: 34003290
[TBL] [Abstract][Full Text] [Related]
2. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
3. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
4. Diversity of cervicovaginal microbiota associated with female lower genital tract infections.
Ling Z; Liu X; Chen X; Zhu H; Nelson KE; Xia Y; Li L; Xiang C
Microb Ecol; 2011 Apr; 61(3):704-14. PubMed ID: 21287345
[TBL] [Abstract][Full Text] [Related]
5. The vaginal microbiota in the course of bacterial vaginosis treatment.
Zwittink RD; van den Munckhof EHA; Leverstein-van Hall MA; Boers K; Molijn A; Knetsch CW; Kuijper EJ
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):651-656. PubMed ID: 33029765
[TBL] [Abstract][Full Text] [Related]
6. The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.
Ling Z; Liu X; Chen W; Luo Y; Yuan L; Xia Y; Nelson KE; Huang S; Zhang S; Wang Y; Yuan J; Li L; Xiang C
Microb Ecol; 2013 Apr; 65(3):773-80. PubMed ID: 23250116
[TBL] [Abstract][Full Text] [Related]
7. Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.
Qin H; Jiao J; A D; Hua M; Han K; Du H; Wang Z; Li J; Zhang D; Xiao B; Chen C
Microbiol Spectr; 2023 Jun; 11(3):e0170622. PubMed ID: 37199621
[TBL] [Abstract][Full Text] [Related]
8. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
[TBL] [Abstract][Full Text] [Related]
9. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.
Fredricks DN; Fiedler TL; Thomas KK; Mitchell CM; Marrazzo JM
J Clin Microbiol; 2009 Mar; 47(3):721-6. PubMed ID: 19144794
[TBL] [Abstract][Full Text] [Related]
10. Association of
Ardizzone CM; Taylor CM; Toh E; Lillis RA; Elnaggar JH; Lammons JW; Mott PD; Duffy EL; Shen L; Quayle AJ
Front Cell Infect Microbiol; 2023; 13():1289449. PubMed ID: 38149008
[TBL] [Abstract][Full Text] [Related]
11. Impact of Periodic Presumptive Treatment for Bacterial Vaginosis on the Vaginal Microbiome among Women Participating in the Preventing Vaginal Infections Trial.
Balkus JE; Srinivasan S; Anzala O; Kimani J; Andac C; Schwebke J; Fredricks DN; McClelland RS
J Infect Dis; 2017 Mar; 215(5):723-731. PubMed ID: 28007924
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
[TBL] [Abstract][Full Text] [Related]
13. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
[TBL] [Abstract][Full Text] [Related]
14. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
[TBL] [Abstract][Full Text] [Related]
15. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
16. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
[TBL] [Abstract][Full Text] [Related]
17. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
[TBL] [Abstract][Full Text] [Related]
18. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
[TBL] [Abstract][Full Text] [Related]
19. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Women and Their Male Sex Partners Predict Bacterial Vaginosis Among a Prospective Cohort of Kenyan Women With Nonoptimal Vaginal Microbiota.
Mehta SD; Agingu W; Nordgren RK; Green SJ; Bhaumik DK; Bailey RC; Otieno F
Sex Transm Dis; 2020 Dec; 47(12):840-850. PubMed ID: 32773610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
